Slow, progressive accumulation of Aβ aggregates triggers AD by initiating a complex pathological cascade that accelerates tau pathology, alters glial cell function and neurodegeneration and ultimately leads to clinical dementia. This evidence concerns the gene MAPT and Alzheimer disease.